Skip to main content

Advertisement

Substance-related disorders, addiction and impulse control

Section edited by Morten Hesse

This section encompasses a range of substance related conditions, alongside addiction and impulse control. Topics of interest include, but are not limited to, problem/pathological gambling, substance abuse, alcohol and drug disorders, impulsive and antisocial behaviors, cannabis disorders and behavioral economics.

Page 4 of 4

  1. Traumatic experiences and, more specifically, posttraumatic stress disorder (PTSD) are highly prevalent among substance use disorder (SUD) patients. This comorbidity is associated with worse treatment outcomes...

    Authors: Tim Kok, Hein A de Haan, Margreet van der Meer, Lisa M Najavits and Cor AJ DeJong

    Citation: BMC Psychiatry 2013 13:162

    Content type: Study protocol

    Published on:

  2. Attention deficit hyperactivity disorder (ADHD) frequently co-occurs with substance use disorders (SUD). The combination of ADHD and SUD is associated with a negative prognosis of both SUD and ADHD. Pharmacolo...

    Authors: Katelijne van Emmerik–van Oortmerssen, Ellen Vedel, Maarten W Koeter, Kim de Bruijn, Jack J M Dekker, Wim van den Brink and Robert A Schoevers

    Citation: BMC Psychiatry 2013 13:132

    Content type: Study protocol

    Published on:

  3. The prevalence of substance use in people acutely admitted to in-patient psychiatric wards is high and the patients` duration of stay is limited. Motivational interviewing is a method with evidence based effec...

    Authors: Gunnhild Bagøien, Johan Håkon Bjørngaard, Christine Østensen, Solveig Klæbo Reitan, Pål Romundstad and Gunnar Morken

    Citation: BMC Psychiatry 2013 13:93

    Content type: Research article

    Published on:

  4. ADHD is a common neurodevelopmental disorder that persists into adulthood. Its symptoms cause impairments in a number of social domains, one of which is employment. We wish to produce a consensus statement on ...

    Authors: Marios Adamou, Muhammad Arif, Philip Asherson, Tar-Ching Aw, Blanca Bolea, David Coghill, Gísli Guðjónsson, Anne Halmøy, Paul Hodgkins, Ulrich Müller, Mark Pitts, Anna Trakoli, Nerys Williams and Susan Young

    Citation: BMC Psychiatry 2013 13:59

    Content type: Correspondence

    Published on:

  5. Medication non-adherence has an important impact on treatment efficacy and healthcare burden across a range of conditions and therapeutic areas. The aim of this analysis was to determine predictors of non-adhe...

    Authors: J J Sandra Kooij, Michael Rösler, Alexandra Philipsen, Sandra Wächter, Joachim Dejonckheere, Annemarie van der Kolk, Michel van Agthoven and Barbara Schäuble

    Citation: BMC Psychiatry 2013 13:36

    Content type: Research article

    Published on:

  6. Assessment of comorbid personality disorders (PDs) in patients with substance use disorders (SUDs) is challenging due to symptom overlap, additional mental and physical disorders, and limitations of the assess...

    Authors: Anne-Marit Langås, Ulrik Fredrik Malt and Stein Opjordsmoen

    Citation: BMC Psychiatry 2012 12:180

    Content type: Research article

    Published on:

  7. While there is increasing evidence on the association between cannabis use and psychotic outcomes, it is still unclear whether this also applies to depression. We aim to assess whether risk of depression and o...

    Authors: Edison Manrique-Garcia, Stanley Zammit, Christina Dalman, Tomas Hemmingsson and Peter Allebeck

    Citation: BMC Psychiatry 2012 12:112

    Content type: Research article

    Published on:

  8. Little research has examined attitudes towards people who use substances in low and middle income countries (LMIC). Therefore, the present study examined the attributions made by the general South African popu...

    Authors: Katherine Sorsdahl, Dan J Stein and Bronwyn Myers

    Citation: BMC Psychiatry 2012 12:101

    Content type: Research article

    Published on:

  9. The prevalence of amphetamine-type stimulant use is greater than that of opioids and cocaine combined. Currently, there are no approved pharmacotherapy treatments for amphetamine-type stimulant problems, but s...

    Authors: Robert J Tait, Rebecca McKetin, Frances Kay-Lambkin, Kylie Bennett, Ada Tam, Anthony Bennett, Jenny Geddes, Adam Garrick, Helen Christensen and Kathleen M Griffiths

    Citation: BMC Psychiatry 2012 12:67

    Content type: Study protocol

    Published on:

  10. Previous population-based studies have found that delusional-like experiences (DLE) are prevalent in the community, and are associated with a wide range of mental health disorders including substance use. The ...

    Authors: Sukanta Saha, James G Scott, Daniel Varghese, Louisa Degenhardt, Tim Slade and John J McGrath

    Citation: BMC Psychiatry 2011 11:202

    Content type: Research article

    Published on: